weight regain after tirzepatide discontinuation Rebound Gain Stopping (Mounjaro or Zepbound) GLP-1 discontinuation: weight-loss drugs work
Description
Tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
These effects collectively improve glycemic control while reducing appetite and food intake
Zepbound is more expensive than Mounjaro because most insurance companies do not provide insurance coverage for Zepbound for weight loss
Nat Med 2022
Mounjaro Dosing Schedule Administer once weekly, on the same day each week, with or without food
Cagrilintide vs
